Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
2.680
-0.200 (-6.94%)
At close: Sep 17, 2025, 4:00 PM EDT
2.690
+0.010 (0.37%)
After-hours: Sep 17, 2025, 6:09 PM EDT
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $14.76 million as of September 17, 2025. Its market cap has increased by 372.27% in one year.
Market Cap
14.76M
Enterprise Value
12.63M
1-Year Change
372.27%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $14.76M, a decrease of -64.17%. That is a compound annual growth rate of -24.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 14.76M | 275.91% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |